Mar 20 2023 |
FDA Modernizes Mammography Regulations, Provides Facilities with Eighteen-Month Compliance Deadline |
Mintz |
Mar 20 2023 |
Antitrust: DOJ Scuttles ACO Guidance, Unsettles Ground Under Provider Joint Contracting Models |
Foley & Lardner LLP |
Mar 20 2023 |
Pennsylvania Commonwealth Court Holds Employer Financially Responsible for Employee’s Medical Marijuana Treatment |
Wilson Elser Moskowitz Edelman & Dicker LLP |
Mar 17 2023 |
Access to Mifepristone Hangs in the Balance |
ArentFox Schiff LLP |
Mar 16 2023 |
Behavioral Health Law Ledger | March 2023 |
Greenberg Traurig, LLP |
Mar 16 2023 |
Gold Dome Report 2023 – Legislative Day 35 |
Nelson Mullins |
Mar 16 2023 |
DOJ Antitrust Division Announces Indictment Against Health Care Staffing Executive For Nurse Wage-Fixing |
Mintz |
Mar 16 2023 |
Trending in Telehealth: March 6 – March 12, 2023 |
McDermott Will & Schulte LLP |
Mar 16 2023 |
The Powers That Shouldn’t Be: Combating Fraud & Exploitation |
Norris McLaughlin P.A. |
Mar 16 2023 |
Diagnosing Health Care: The End of the Public Health Emergency – What’s to Come? [PODCAST] |
Epstein Becker & Green, P.C. |
Mar 16 2023 |
The Active Adult Market: Senior Living, Multifamily, or Both? |
ArentFox Schiff LLP |
Mar 16 2023 |
As COVID-19 Emergency Waivers End, DEA Proposes to Expand Tele-Prescribing of Controlled Substances |
Robinson & Cole LLP |
Mar 16 2023 |
CMS Issues Guidance for Providers on Waivers, Flexibilities and End of COVID-19 Public Health Emergency |
Robinson & Cole LLP |
Mar 15 2023 |
This Week in 340B: March 7 – 13, 2023 |
McDermott Will & Schulte LLP |
Mar 15 2023 |
CMS Releases First Set of Part B Rebatable Drugs for Coinsurance Adjustment Under IRA |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 15 2023 |
2022 Medicaid Fraud Control Unit Data Shows Continued Focus On Fraud Criminal Convictions |
Barnes & Thornburg LLP |
Mar 15 2023 |
PBM Practices Receive Increased Federal Scrutiny |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 15 2023 |
Coverage of COVID-19 Vaccines and the End of the COVID-19 Emergency |
McDermott Will & Schulte LLP |
Mar 15 2023 |
Ch-ch-ch-ch-changes – Mississippi Legislature Makes Key Amendments to Medical Cannabis Act |
Bradley Arant Boult Cummings LLP |
Mar 14 2023 |
The AI Search Engine Doctor Is Always In: What Are the Regulatory and Legal Implications? |
Mintz |
Mar 14 2023 |
DEA Issues Proposed Rule for Prescribing of Controlled Substances via Telemedicine |
Bradley Arant Boult Cummings LLP |
Mar 14 2023 |
Tracking the Waivers: Implications of the Wind Down of the COVID-19 Public Health Emergency |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 13 2023 |
Deja Vu or a Glitch in the Matrix: The End of the Public Health Emergency |
Dinsmore & Shohl LLP |
Mar 13 2023 |
Federal Trade Commission’s GoodRx Settlement: Not Just a $1.5 Million Penalty |
Mintz |
Mar 13 2023 |
Trending in Telehealth: February 27 – March 5, 2023 |
McDermott Will & Schulte LLP |
Mar 10 2023 |
California Office of Health Care Affordability: Another Regulatory Hurdle for California Healthcare M&A Transactions? |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 10 2023 |
DOJ and SEC Charge Healthcare Executive With Trading on Negative Information Known at the Time of Adopting Rule 10b5-1 Trading Plans |
McDermott Will & Schulte LLP |
Mar 10 2023 |
Proposed Changes to Dsh Payment Calculation Regulations Could Impact 340B Hospitals |
McDermott Will & Schulte LLP |
Mar 10 2023 |
Ramifications of FDA’s Proposed Action Levels for Heavy Metals in Baby Food |
Womble Bond Dickinson (US) LLP |
Mar 10 2023 |
Lead Exposure in Children |
Womble Bond Dickinson (US) LLP |
Mar 10 2023 |
What the End of the COVID-19 Pandemic Means for Employee Benefit Plan Deadlines and Coverage |
Jackson Lewis P.C. |
Mar 10 2023 |
HHS Argues Pharmaceutical Proposal Involves Quid Pro Quo Exchanges |
ArentFox Schiff LLP |
Mar 10 2023 |
District Court Vacates Provisions of No Surprises Act Final Rule |
McDermott Will & Schulte LLP |
Mar 9 2023 |
Air Ambulance Cost Reporting Delayed Until Rules are Finalized |
Foley & Lardner LLP |
Mar 9 2023 |
MSSP VS ACO REACH: Five Considerations for Legal Counsel |
K&L Gates LLP |